-
公开(公告)号:WO2021222927A1
公开(公告)日:2021-11-04
申请号:PCT/US2021/070459
申请日:2021-04-27
IPC分类号: A61K35/17 , A61P35/00 , C07K14/725 , C07K16/28 , C07K14/705
摘要: Virus-specific immune cells, comprising a chimeric antigen receptor (CAR) or nucleic acid encoding a CAR, wherein the CAR comprises: (i) an antigen-binding domain which binds specifically to CD30, (ii) a transmembrane domain, and (iii) a signalling domain, wherein the signalling domain comprises: (a) an amino acid sequence derived from the intracellular domain of CD28, and (b) an amino acid sequence comprising an immunoreceptor tyrosine-based activation motif (ITAM), are disclosed. Also disclosed are methods for producing and compositions comprising such cells.
-
公开(公告)号:WO2022232797A2
公开(公告)日:2022-11-03
申请号:PCT/US2022/071950
申请日:2022-04-27
IPC分类号: C12N5/0783 , A61K35/17 , A61K39/245 , C07K14/05 , A61P35/02 , A61K2039/5156 , A61K39/001112 , A61K39/001129 , C07K14/005 , C12N2501/2302 , C12N2501/2307 , C12N2501/2315 , C12N2501/51 , C12N2501/515 , C12N2501/998 , C12N2506/11 , C12N2510/00 , C12N2710/16234 , C12N5/0636
摘要: Embodiments of the disclosure encompass methods for generating or expanding a population of immune cells specific for a virus, comprising stimulating immune cells specific for a virus by culturing peripheral blood mononuclear cells (PBMCs) in cell culture medium comprising human platelet lysate in the presence of: (i) one or more peptides corresponding to all or part of one or more antigens of the virus; or (ii) antigen presenting cells (APCs) presenting one or more peptides corresponding to all or part of one or more antigens of the virus. In particular embodiments, the cell culture medium comprises a particular percentage of human platelet lysate and/or the PBMCs are depleted of CD45RA-positive cells, for example.
-
3.
公开(公告)号:WO2021222929A1
公开(公告)日:2021-11-04
申请号:PCT/US2021/070461
申请日:2021-04-27
IPC分类号: A61K35/17 , A61P35/00 , C07K14/725 , C07K16/28 , C07K14/705
摘要: Treatment and prevention of diseases/conditions characterised by an alloreactive immune response using virus-specific immune cells, comprising a chimeric antigen receptor (CAR) or nucleic acid encoding a CAR, wherein the CAR comprises: (i) an antigen-binding domain which binds specifically to CD30, (ii) a transmembrane domain, and (iii) a signalling domain, wherein the signalling domain comprises: (a) an amino acid sequence derived from the intracellular domain of CD28, and (b) an amino acid sequence comprising an immunoreceptor tyrosine-based activation motif (ITAM), is disclosed.
-
4.
公开(公告)号:WO2021222928A1
公开(公告)日:2021-11-04
申请号:PCT/US2021/070460
申请日:2021-04-27
IPC分类号: A61K35/17 , A61P35/00 , C07K14/725 , C07K16/28 , C07K14/705
摘要: Treatment and prevention of cancer using virus-specific immune cells, comprising a chimeric antigen receptor (CAR) or nucleic acid encoding a CAR, wherein the CAR comprises: (i) an antigen-binding domain which binds specifically to CD30, (ii) a transmembrane domain, and (iii) a signalling domain, wherein the signalling domain comprises: (a) an amino acid sequence derived from the intracellular domain of CD28, and (b) an amino acid sequence comprising an immunoreceptor tyrosine-based activation motif (ITAM), is disclosed.
-
-
-